Glycolaldehyde induces oxidative stress in the heart: A clue to diabetic cardiomyopathy?

Cardiovascular Toxicology

Volumn 10, Issue 4, 2010, Pages 244-249

  Lorenzi, Rodrigo ^a   Andrades, Michael Everton ^a   Bortolin, Rafael Calixto ^a   Nagai, Ryoji ^c   Dal Pizzol, Felipe ^b   Moreira, José Cláudio Fonseca ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c JAPAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Glycation; Glycolaldehyde; Oxidative stress

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ALDEHYDE DERIVATIVE; CATALASE; GLYCOLALDEHYDE; LACTOYLGLUTATHIONE LYASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT;

ACETALDEHYDE; ANIMALS; CARDIOMYOPATHIES; CATALASE; DIABETES COMPLICATIONS; INJECTIONS, INTRAVENOUS; LACTOYLGLUTATHIONE LYASE; LIPID PEROXIDATION; LYSINE; MALE; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; TIME FACTORS;

RATTUS NORVEGICUS;

EID: 78649906889     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-010-9083-x     Document Type: Article

References (46)

1. A D'Souza M Hussain FC Howarth NM Woods K Bidasee J Singh 2009 Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart Molecular and Cellular Biochemistry 331 89 116 10.1007/s11010-009-0148-8 19466528
2. A Natali S Vichi P Landi S Severi A L'Abbate E Ferrannini 2000 Coronary atherosclerosis in Type II diabetes: Angiographic findings and clinical outcome Diabetologia 43 632 641 1:STN:280:DC%2BD3cvislGgsA%3D%3D 10.1007/s001250051352 10855538 (Pubitemid 30322081)
3. (1999). Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes, 48, 383-390.
4. A Vinik M Flemmer 2002 Diabetes and macrovascular disease Journal of Diabetes Complications 16 235 245 10.1016/S1056-8727(01)00212-4 (Pubitemid 34553332)
5. S Yamagishi T Imaizumi 2005 Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy Current Pharmaceutical Design 11 2279 2299 1:CAS:528:DC%2BD2MXlsV2gtL0%3D 10.2174/1381612054367300 16022668 (Pubitemid 40872698)
6. S Yamagishi 2009 Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications Therapeutic Apheresis and Dialysis 13 534 539 1:CAS:528:DC%2BC3cXht1Ohurk%3D 10.1111/j.1744-9987.2009. 00775.x 19954478
7. H Choei N Sasaki M Takeuchi T Yoshida W Ukai S Yamagishi S Kikuchi T Saito 2004 Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease Acta Neuropathologica 108 189 193 1:CAS:528:DC%2BD2cXmt1Krtbc%3D 10.1007/s00401-004-0871-x 15221334
8. M Peppa J Uribarri H Vlassara 2008 Aging and glycoxidant stress Hormones (Athens) 7 123 132
9. E Yagmur F Tacke C Weiss B Lahme MP Manns P Kiefer C Trautwein AM Gressner 2006 Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis Clinical Biochemistry 39 39 45 1:CAS:528:DC%2BD28Xks1Oj 10.1016/j.clinbiochem.2005.07.016 16321365 (Pubitemid 43005268)
10. RD Semba JC Fink K Sun BG Windham L Ferrucci 2010 Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: The Baltimore longitudinal study of aging Journal of Renal Nutrition 20 74 81 10.1053/j.jrn.2009.08.001 19853477
11. D Aronson 2003 Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes Journal of Hypertension 21 3 12 1:CAS:528:DC%2BD3sXlsVyqtw%3D%3D 10.1097/00004872-200301000-00002 12544424 (Pubitemid 36143498)
12. PM Humpert IK Lukic SR Thorpe S Hofer EM Awad M Andrassy EK Deemer M Kasper E Schleicher M Schwaninger MA Weigand PP Nawroth A Bierhaus 2009 AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis Journal of Leukocyte Biology 86 589 597 1:CAS:528:DC%2BD1MXhtFahtb7I 10.1189/jlb.1008646 19401390
13. AL Tan KC Sourris BE Harcourt V Thallas-Bonke S Penfold S Andrikopoulos MC Thomas RC O'Brien A Bierhaus ME Cooper JM Forbes MT Coughlan 2010 Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy American Journal of Physiology and Renal Physiology 298 F763 F770 1:CAS:528:DC%2BC3cXjsFGnu7o%3D 10.1152/ajprenal.00591.2009
14. K Kamata Y Ozawa T Kobayashi T Matsumoto 2009 Effect of N-epsilon-(carboxymethyl)lysine on coronary vasoconstriction in isolated perfused hearts from control and streptozotocin-induced diabetic rats Journal of Smooth Muscle Research 45 125 137 10.1540/jsmr.45.125 19602856
15. A Shirpoor S Salami MH Khadem-Ansari B Ilkhanizadeh FG Pakdel K Khademvatani 2009 Cardioprotective effect of vitamin E: Rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat Journal of Diabetes and Its Complications 23 310 316 10.1016/j.jdiacomp.2008.02. 009 18394933
16. VZ Lankin MO Lisina NE Arzamastseva GG Konovalova LV Nedosugova AI Kaminnyi AK Tikhaze FT Ageev VV Kukharchuk YN Belenkov 2005 Oxidative stress in atherosclerosis and diabetes Bulletin of Experimental Biology and Medicine 140 41 43 1:CAS:528:DC%2BD2MXhtVOhu7%2FK 10.1007/s10517-005-0406-z 16254616 (Pubitemid 41548626)
17. A Gumieniczek 2005 Modification of cardiac oxidative stress in alloxan-induced diabetic rabbits with repaglinide treatment Life Science 78 259 263 1:CAS:528:DC%2BD2MXhtFOgtr%2FM 10.1016/j.lfs.2005.04.074 (Pubitemid 41570195)
18. MA Glomb VM Monnier 1995 Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction Journal of Biological Chemistry 270 10017 10026 1:CAS:528:DyaK2MXltlWnsrY%3D 10.1074/jbc.270.17.10017 7730303
19. MM Anderson SL Hazen FF Hsu JW Heinecke 1997 Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation Journal of Clinical Investigation 99 424 432 1:CAS:528:DyaK2sXhtVKksbg%3D 10.1172/JCI119176 9022075
20. KS Al-Enezi M Alkhalaf LT Benov 2006 Glycolaldehyde induces growth inhibition and oxidative stress in human breast cancer cells Free Radical Biology and Medicine 40 1144 1151 1:CAS:528:DC%2BD28Xis1egtbo%3D 10.1016/j.freeradbiomed.2005.10.065 16545681
21. ME Andrades R Lorenzi M Berger JA Guimaraes JC Moreira F Dal-Pizzol 2009 Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion Chemico-Biological Interactions 180 478 484 1:CAS:528:DC%2BD1MXnsFarsrg%3D 10.1016/j.cbi.2009.04.005 19397901
22. K Mera K Takeo M Izumi T Maruyama R Nagai M Otagiri 2010 Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin Journal of Pharmaceutical Sciences 99 1614 1625 1:CAS:528:DC%2BC3cXmvVGhuw%3D%3D 19760671
23. BE Brown RT Dean MJ Davies 2005 Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells Diabetologia 48 361 369 1:CAS:528:DC%2BD2MXhvF2ruro%3D 10.1007/s00125-004-1648-4 15660260 (Pubitemid 40543310)
24. PE Morgan RT Dean MJ Davies 2002 Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products Archives of Biochemistry and Biophysics 403 259 269 1:CAS:528:DC%2BD38XlsFKgu7k%3D 10.1016/S0003-9861(02)00222-9 12139975 (Pubitemid 34800207)
25. H Ukeda Y Hasegawa T Ishi M Sawamura 1997 Inactivation of Cu, Zn-superoxide dismutase by intermediates of Maillard reaction and glycolytic pathway and some sugars Bioscience, Biotechnology, and Biochemistry 61 2039 2042 1:CAS:528:DyaK1cXltFSmsA%3D%3D 10.1271/bbb.61.2039 9438984
26. HB Lee MD Blaufox 1985 Blood volume in the rat Journal of Nuclear Medicine 26 72 76 1:STN:280:DyaL2M%2Fot1ehsQ%3D%3D 3965655
27. RL Levine JA Williams ER Stadtman E Shacter 1994 Carbonyl assays for determination of oxidatively modified proteins Methods in Enzymology 233 346 357 1:CAS:528:DyaK2cXmt1GgtLw%3D 10.1016/S0076-6879(94)33040-9 8015469
28. Draper, H. H., Hadley, M., Lester, P., & Alexander, N. G. (1990). [43] Malondialdehyde determination as index of lipid peroxidation. In Methods in enzymology (pp 421-431), Academic Press.
29. GL Ellman 1959 Tissue sulfhydryl groups Archives of Biochemistry and Biophysics 82 70 77 1:CAS:528:DyaG1MXotl2ksA%3D%3D 10.1016/0003-9861(59)90090-6 13650640
30. Aebi, H., & Lester, P. (1984). [13] Catalase in vitro. In Methods in enzymology (pp 121-126), Academic Press.
31. HP Misra I Fridovich 1972 The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase The Journal of Biological Chemistry 247 3170 3175 1:CAS:528:DyaE38XhsFSntLk%3D 4623845
32. B Mannervik AC Aronsson E Marmstal G Tibbelin 1981 Glyoxalase I (rat liver) Methods in Enzymology 77 297 301 1:CAS:528:DyaL38XhtFyjs7w%3D 10.1016/S0076-6879(81)77041-1 6173571
33. Y Imanaga N Sakata S Takebayashi A Matsunaga J Sasaki K Arakawa R Nagai S Horiuchi H Itabe T Takano 2000 In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques Atherosclerosis 150 343 355 1:CAS:528:DC%2BD3cXktVSmsr8%3D 10.1016/S0021- 9150(99)00396-2 10856526 (Pubitemid 30336546)
34. TJ Mocatta AP Pilbrow VA Cameron R Senthilmohan CM Frampton AM Richards CC Winterbourn 2007 Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction Journal of the American College of Cardiology 49 1993 2000 1:CAS:528:DC%2BD2sXlsF2hur4%3D 10.1016/j.jacc.2007.02.040 17512353 (Pubitemid 46734639)
35. SF Yan R Ramasamy AM Schmidt 2010 The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature Circulation Research 106 842 853 1:CAS:528:DC%2BC3cXjs1aku7w%3D 10.1161/CIRCRESAHA.109.212217 20299674
36. L Park KG Raman KJ Lee Y Lu LJ Ferran Jr WS Chow D Stern AM Schmidt 1998 Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nature Medicine 4 1025 1031 1:CAS:528: DyaK1cXlvFGjurw%3D 10.1038/2012 9734395 (Pubitemid 28417334)
37. Y Kono I Fridovich 1982 Superoxide radical inhibits catalase The Journal of Biological Chemistry 257 5751 5754 1:CAS:528:DyaL38XktVakt7g%3D 6279612
38. M Adrover B Vilanova F Munoz J Donoso 2008 Kinetic study of the reaction of glycolaldehyde with two glycation target models Annals of the New York Academy of Sciences 1126 235 240 1:CAS:528:DC%2BD1cXmtFynsrc%3D 10.1196/annals.1433.008 18079476 (Pubitemid 351589270)
39. N Ballatori SM Krance S Notenboom S Shi K Tieu CL Hammond 2009 Glutathione dysregulation and the etiology and progression of human diseases Biological Chemistry 390 191 214 1:CAS:528:DC%2BD1MXivFeis7w%3D 10.1515/BC.2009.033 19166318
40. CE Paulsen KS Carroll 2010 Orchestrating redox signaling networks through regulatory cysteine switches ACS Chemical Biology 5 47 62 1:CAS:528: DC%2BD1MXhsFKks7jI 10.1021/cb900258z 19957967
41. DL Vander Jagt RK Hassebrook LA Hunsaker WM Brown RE Royer 2001 Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: Roles for glutathione in both enzymes and implications for diabetic complications Chemico-Biological Interactions 130-132 549 562 10.1016/S0009-2797(00)00298-2 11306074 (Pubitemid 32295843)
42. M Atalay NK Oksala DE Laaksonen S Khanna C Nakao J Lappalainen S Roy O Hanninen CK Sen 2004 Exercise training modulates heat shock protein response in diabetic rats Journal of Applied Physiology 97 605 611 1:CAS:528: DC%2BD2cXmvFagsr0%3D 10.1152/japplphysiol.01183.2003 15075301 (Pubitemid 38963131)
43. Aydemir-Koksoy, A., Bilginoglu, A., Sariahmetoglu, M., Schulz, R., & Turan, B. (2009). Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress. Journal of Nutritional Biochemistry.
44. A Bilginoglu A Seymen E Tuncay E Zeydanli A Aydemir-Koksoy B Turan 2009 Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats Cardiovascular Toxicology 9 21 29 1:CAS:528:DC%2BD1MXkt1yhu7g%3D 10.1007/s12012-009-9032-8 19294534
45. R Nagai Y Fujiwara K Mera K Motomura Y Iwao K Tsurushima M Nagai K Takeo M Yoshitomi M Otagiri T Ikeda 2008 Usefulness of antibodies for evaluating the biological significance of AGEs Annals of the New York Academy of Sciences 1126 38 41 1:CAS:528:DC%2BD1cXmtFygtbw%3D 10.1196/annals.1433.001 18079488 (Pubitemid 351589264)
46. R Nagai CM Hayashi L Xia M Takeya S Horiuchi 2002 Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins Journal of Biological Chemistry 277 48905 48912 1:CAS:528:DC%2BD38Xptlent7c%3D 10.1074/jbc.M205688200 12377783 (Pubitemid 35470860)